TY - JOUR
T1 - The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity
AU - Carr, Molly C.
AU - Hokanson, John E.
AU - Zambon, Alberto
AU - Deeb, Samir S.
AU - Barrett, P. Hugh R.
AU - Purnell, Jonathan Q.
AU - Brunzell, John D.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - Hepatic lipase (HL) hydrolyzes triglyceride and phospholipid in low and high density lipoprotein cholesterol (LDL-C and HDL-C, respectively), and elevated HL activity is associated with small, dense atherogenic LDL particles and reduced HDL2-C. Elevated HL activity is associated with increasing age, male gender, high amounts of intraabdominal fat (IAF), and the HL gene (LIPC) promoter polymorphism (C nucleotide at -514). We investigated the mechanisms underlying the difference in HL activity between men (n = 44) and premenopausal women (n = 63). Men had significantly more IAF (144.5 ± 80.9 vs. 66.5 ± 43.2 cm2, respectively; P < 0.001), higher HL activity (220.9 ± 94.7 vs.129.9 ± 53.5 nmol/mL·min; P < 0.001), more dense LDL (Rf, 0.277 ± 0.032 vs. 0.300 ± 0.024; P = 0.01), and less HDL2-C (0.19 ± 0.10 vs. 0.32 ± 0.16 mmol/L; P < 0.001) than women. After adjusting for IAF and the LIPC polymorphism, men continued to have higher (but attenuated) HL activity (194.5 ± 80.4 vs. 151.0 ± 45.2, respectively; P = 0.007) and lower HDL2-C (0.23 ± 0.11 vs. 0.29 ± 0.14 mmol/L; P = 0.02) than women. Using multiple regression, HL activity remained independently related to IAF (P < 0.001), gender (P < 0.001), and the LIPC genotype (P < 0.001), with these factors accounting for 50% of the variance in HL activity. These data suggest that IAF is a major component of the gender difference in HL activity, but other gender-related differences, perhaps sex steroid hormones, also contribute to the higher HL activity seen in men compared with premenopausal women. The higher HL activity in men affects both LDL and HDL heterogeneity and may contribute to the gender difference in cardiovascular risk.
AB - Hepatic lipase (HL) hydrolyzes triglyceride and phospholipid in low and high density lipoprotein cholesterol (LDL-C and HDL-C, respectively), and elevated HL activity is associated with small, dense atherogenic LDL particles and reduced HDL2-C. Elevated HL activity is associated with increasing age, male gender, high amounts of intraabdominal fat (IAF), and the HL gene (LIPC) promoter polymorphism (C nucleotide at -514). We investigated the mechanisms underlying the difference in HL activity between men (n = 44) and premenopausal women (n = 63). Men had significantly more IAF (144.5 ± 80.9 vs. 66.5 ± 43.2 cm2, respectively; P < 0.001), higher HL activity (220.9 ± 94.7 vs.129.9 ± 53.5 nmol/mL·min; P < 0.001), more dense LDL (Rf, 0.277 ± 0.032 vs. 0.300 ± 0.024; P = 0.01), and less HDL2-C (0.19 ± 0.10 vs. 0.32 ± 0.16 mmol/L; P < 0.001) than women. After adjusting for IAF and the LIPC polymorphism, men continued to have higher (but attenuated) HL activity (194.5 ± 80.4 vs. 151.0 ± 45.2, respectively; P = 0.007) and lower HDL2-C (0.23 ± 0.11 vs. 0.29 ± 0.14 mmol/L; P = 0.02) than women. Using multiple regression, HL activity remained independently related to IAF (P < 0.001), gender (P < 0.001), and the LIPC genotype (P < 0.001), with these factors accounting for 50% of the variance in HL activity. These data suggest that IAF is a major component of the gender difference in HL activity, but other gender-related differences, perhaps sex steroid hormones, also contribute to the higher HL activity seen in men compared with premenopausal women. The higher HL activity in men affects both LDL and HDL heterogeneity and may contribute to the gender difference in cardiovascular risk.
UR - http://www.scopus.com/inward/record.url?scp=0034977473&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034977473&partnerID=8YFLogxK
U2 - 10.1210/jc.86.6.2831
DO - 10.1210/jc.86.6.2831
M3 - Article
C2 - 11397895
AN - SCOPUS:0034977473
SN - 0021-972X
VL - 86
SP - 2831
EP - 2837
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 6
ER -